|
1
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kagawa S, Shigeyasu K, Ishida M, Watanabe
M, Tazawa H, Nagasaka T, Shirakawa Y and Fujiwara T: Molecular
diagnosis and therapy for occult peritoneal metastasis in gastric
cancer patients. World J Gastroenterol. 20:17796–17803. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen
WM, Huang MD and Shu YQ: SP1-induced upregulation of the long
noncoding RNA TINCR regulates cell proliferation and apoptosis by
affecting KLF2 mRNA stability in gastric cancer. Oncogene.
34:5648–5661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W and Chen Jf: Long noncoding RNA
ANRIL indicates a poor prognosis of gastric cancer and promotes
tumor growth by epigenetically silencing of miR-99a/miR-449a.
Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses
epithelial-mesenchymal transition in gastric cancer. Int J Biol
Sci. 9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Endo H, Shiroki T, Nakagawa T, Yokoyama M,
Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, et
al: Enhanced expression of long non-coding RNA HOTAIR is associated
with the development of gastric cancer. PLoS One. 8:e770702013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang EB, Han L, Yin DD, Kong R, De W and
Chen J: c-Myc-induced, long, noncoding H19 affects cell
proliferation and predicts a poor prognosis in patients with
gastric cancer. Med Oncol. 31:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hamilton SR and Aaltonen LA: World Health
Organization Classifcation of Tumours. Pathology and genetics of
tumours of the digestive system. International Agency for Research
on Cancer (IARC) Press; Lyon, Paris: 2000
|
|
15
|
Sobin LH, Gospodarowicz M and Wittekind C:
International Union Against Cancer (UICC). TNM classifcation of
malignant tumours. 7th edition. Hoboken, NJ: Wiley-Liss, New York,
NY, USA; pp. 117–126. 2010
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiel A and Ristimäki A: Gastric cancer:
Basic aspects. Helicobacter. 17 Suppl 1:S26–S29. 2012. View Article : Google Scholar
|
|
19
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu W, Alvarez-Dominguez JR and Lodish HF:
Regulation of mammalian cell differentiation by long non-coding
RNAs. EMBO Rep. 13:971–983. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaikkonen MU, Lam MT and Glass CK:
Non-coding RNAs as regulators of gene expression and epigenetics.
Cardiovasc Res. 90:430–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee NK, Lee JH, Park CH, Yu D, Lee YC,
Cheong JH, Noh SH and Lee SK: Long non-coding RNA HOTAIR promotes
carcinogenesis and invasion of gastric adenocarcinoma. Biochem
Biophys Res Commun. 451:171–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kretz M, Siprashvili Z, Chu C, Webster DE,
Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, et al:
Control of somatic tissue differentiation by the long non-coding
RNA TINCR. Nature. 493:231–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
28
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
30
|
Bravo Neto GP, dos Santos EG, Victer FC
and Carvalho CE: Lymph node metastasis in early gastric cancer. Rev
Col Bras Cir. 41:11–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu M, Zhou Y, Zhang X, Wang Z, Wang F,
Shao J, Lu J, Jin Y, Wei X, Zhang D, et al: Lauren classification
combined with HER2 status is a better prognostic factor in Chinese
gastric cancer patients. BMC Cancer. 14:8232014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Polkowski W, van Sandick JW, Offerhaus GJ,
ten Kate FJ, Mulder J, Obertop H and van Lanschot JJ: Prognostic
value of Laurén classification and c-erbB-2 oncogene overexpression
in adenocarcinoma of the esophagus and gastroesophageal junction.
Ann Surg Oncol. 6:290–297. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaneko S and Yoshimura T: Time trend
analysis of gastric cancer incidence in Japan by histological
types, 1975-1989. Br J Cancer. 84:400–405. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Parsonnet J, Vandersteen D, Goates J,
Sibley RK, Pritikin J and Chang Y: Helicobacter pylori infection in
intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer
Inst. 83:640–643. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
